Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019. (19th November 2021)

• Record Type: Journal Article
• Authors: McCluskey, Gavin; Duddy, William; Haffey, Stephen; Morrison, Karen; Donaghy, Colette; Duguez, Stephanie
• Is Part Of: European journal of neurology. Volume 29:Number 3(2022)
• Page Start: 707
• Page End: 714
• Publication Date: 2021-11-19
• Subjects: amyotrophic lateral sclerosis -- epidemiology -- incidence -- motor neurone disease -- survival; Neurology -- Periodicals; Nervous system -- Diseases -- Periodicals; 616.8
• DOI: 10.1111/ene.15172
• Languages: English
• ISSNs: 1351-5101

Abstract

Abstract: Background and purpose: This study evaluates the incidence, prevalence and survival trends of motor neurone disease (MND) in Northern Ireland from 2015 to 2019. Methods: A capture–recapture analysis was performed using five independent data sources. Incidence and prevalence rates were standardized to the European Standard Population. Survival outcomes were analysed using Kaplan–Meier curves and Cox regression analysis. Results: Amongst 254 total cases of MND, capture–recapture analysis estimated three missing cases (case ascertainment 98.8%). Age standardized incidence of captured cases was 3.12 per 100, 000 (2.73, 3.50) and standardized prevalence ranged from 9.45 to 6.49 per 100, 000 from 2015 to 2019. Standardized incidence and prevalence rates in 2006 were 1.4 and 3.3 per 100, 000 respectively. Of identified cases, 133 (52.4%) were male; 94.5% had amyotrophic lateral sclerosis; median age of onset was 67 years; median time to diagnosis was 12 months (95% confidence interval 11.2, 12.8); survival from diagnosis was 12 months (95% confidence interval 10.6, 15.4); 25 (9.8%) reported a family history of MND or frontotemporal dementia; and a known MND‐associated genetic mutation was identified in 7.9% of total cases, of which the most common was C9orf72 (5.7% of all patients). Factors associated with improved survival were younger age at onset, longer time to diagnosis, attendance at regional MND clinic, and initial neurology presentation as outpatient (all p < 0.001). Conclusion: The incidence and prevalence of MND in Northern Ireland has increased over the last 10 years, in line with increasing rates reported from other European countries. Improved survival was associated with younger age at onset, longer time to diagnosis, attendance at a regional MND clinic and outpatient presentation to a Neurology Department. Abstract : This study evaluates the incidence, prevalence and survival trends of motor neurone disease (MND) in Northern Ireland from 2015 to 2019. Age standardized incidence of captured cases was 3.12 per 100, 000 (2.73, 3.50) and standardized prevalence ranged from 9.45 to 6.49 per 100, 000 from 2015 to 2019, which has increased over the last 10 years. Improved survival was associated with younger age at onset, longer time to diagnosis, attendance at a regional MND clinic and outpatient presentation to a Neurology Department.